Kathleen M Phelan

Title: **Innovative Contributions of Kathleen M. Phelan in the Field of Biomedical Research**

Introduction

Kathleen M. Phelan, based in Gurnee, IL, is a remarkable inventor recognized for her significant contributions to biomedical research. With a total of two patents to her name, she has focused her work on critical health issues, particularly regarding the melanin-concentrating hormone and its receptor.

Latest Patents

Her latest patent is titled "Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor." This invention addresses the antagonism of the effects of melanin-concentrating hormone (MCH), making it potentially beneficial for the prevention or treatment of various conditions, including eating disorders, obesity, reproductive abnormalities, and psychiatric disorders. Her second patent, "Cyclic and bicyclic diamino histamine-3 receptor antagonists," further demonstrates her commitment to exploring novel solutions in healthcare.

Career Highlights

Kathleen currently works with Abbott Laboratories Corporation, a leading global healthcare company dedicated to helping people live their best lives through the development of innovative products. Her role within the organization showcases her expertise and dedication to advancing medical science.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues such as Anil Vasudevan and Youssef L. Bennani. These collaborations have amplified her research efforts and contributed to the successful development of her patented innovations.

Conclusion

Kathleen M. Phelan stands out as a talented inventor making strides in biomedical research. Her patents not only reflect her innovative mindset but also her commitment to addressing pressing medical challenges. As she continues her work at Abbott Laboratories Corporation, her contributions will undoubtedly lead to further advancements in the field.